Pharmaceutical formulation
US8084445B2 · kind B2 · utility
11Cited by
28References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2005 |
| Grant date | Dec 27, 2011 |
| Priority date | — |
| Expiry date | Nov 1, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are novel formulations for the treatment of otic infections in an animal comprising a triazole anti-fungal compound, a quinolone antibiotic and a corticosteroid such as mometasone furoate monohydrate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.